A case of ventricular fibrillation as a consequence of capecitabine-induced secondary QT prolongation: A case report

Capecitabine is an oral fluoropyrimidine which can prolong QT interval. However, there have been no reports that capecitabine induced ventricular fibrillation (VF) due to secondary QT prolongation in patients with no structural heart disease. A 39-year-old woman developed VF during the chemotherapy...

Полное описание

Сохранить в:
Библиографические подробности
Опубликовано в: :J Cardiol Cases
Главные авторы: Hayasaka, Kazuto, Takigawa, Masateru, Takahashi, Atsushi, Kuwahara, Taishi, Okubo, Kenji, Tanaka, Yasuaki, Misawa, Toru, Mizusawa, Masafumi, Yamakami, Yosuke, Kojima, Keisuke, Sagawa, Yuichiro, Hishikari, Keiichi, Yamao, Kazuya, Nakashima, Emiko, Nakajima, Jun, Kimura, Shigeki, Takagi, Katsumasa, Hikita, Hiroyuki, Isobe, Mitsuaki
Формат: Artigo
Язык:Inglês
Опубликовано: Japanese College of Cardiology 2017
Предметы:
Article
Online-ссылка:https://ncbi.nlm.nih.gov/pmc/articles/PMC6149258/
https://ncbi.nlm.nih.gov/pubmed/30279790
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.jccase.2017.03.009
Метки: Добавить метку
Нет меток, Требуется 1-ая метка записи!

Схожие документы